1. Moore PF. A review of histiocytic diseases of dogs and cats. Vet Pathol 2014;51:167–184.
2. Fulmer AK, Mauldin GE. Canine histiocytic neoplasia: an overview. Can Vet J 2007;48:1041–1043.
3. Moore PF, Affolter VK, Vernau W. Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages. Vet Pathol 2006;43:632–645.
4. Abadie J, Hedan B, Cadieu E, et al. Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed. J Hered 2009;100(suppl 1):S19–S27.
5. Constantino-Casas F, Mayhew D, Hoather TM, et al. The clinical presentation and histopathologic-immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever. Vet Pathol 2011;48:764–771.
6. Takahashi M, Tomiyasu H, Hotta E, et al. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. J Vet Med Sci 2014;76:661–666.
7. Kagawa Y, Nakano Y, Kobyashi T, et al. Localized pulmonary histiocytic sarcomas in Pembroke Welsh Corgi. J Vet Med Sci 2016;77:1659–1661.
8. Pierezan F, Mansell J, Ambrus A, et al. Immunohistochemical expression of ionized calcium binding adaptor molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats. J Comp Pathol 2014;151:347–351.
9. Caine GJ, Stonelake PS, Lip GY, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465–473.
Advertisement